Negative regulation of response to type II interferon

pathway activity — cross-omics
GO:0060331Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of response to type II interferon pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Leukemia cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ARHGDIB, RB1, and CACFD1, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of response to type II interferon activity versus ARHGDIB in BLOOD_Leukemia (Pearson r = -0.44).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaARHGDIB →-1.369-0.685.002.00432
BLOOD_LeukemiaRB1 →-0.739-0.824.003<.00132
BLOOD_LeukemiaCACFD1 →-1.135-0.971.008<.00132
BLOOD_LeukemiaCRELD1 →+1.001+1.112.002<.00132
PANCREASZNF597 →+0.939+0.146.001.00832
PANCREASINSIG1 →-1.608-0.158.005.00232
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0060331 vs ARHGDIB — BLOOD_Leukemia

Per-sample scatter of Negative regulation of response to type II interferon activity vs ARHGDIB in BLOOD_Leukemia.

Explore this scatter interactively →

Exploration